Last summer, the Food and Drug Administration denied an application for a new antifungal drug called olorofim, sending it back to the company with a request for more data. If approved, it would have ...
Invasive fungal infections are now estimated to affect about 6.5 million people every year around the world, and while many ...
In the trial, aimed at evaluating the safety and efficacy of once-weekly Rezzayo, the drug demonstrated a profile comparable with standard antimicrobial regimen in reducing the incidence of invasive ...
Mundipharma and CorMedix have unveiled a win for their antifungal drug Rezzayo at preventing invasive fungal diseases in ...
Serious fungal infections are on the rise, and many hospital-acquired cases are becoming harder to treat as fungi become ...
The discovery of a new preclinical compound with strong antifungal activity against multidrug-resistant pathogens is described in Nature. The drug, named mandimycin, is a member of a known family of ...
DURHAM, N.C. -- For the roughly 150,000 patients with AIDS who come down with a life-threatening infection called fungal meningitis each year, there aren’t many options. In many parts of the world ...
The city's health department is advising providers to increase screening for C. auris, which can lead to life-threatening ...
With biochemical analysis, state-of-the-art imaging technology and computer simulations, research led by scientists at Michigan State University has shown how fungi remodel their cell walls to thwart ...
On September 26, 2023, the U.S. Environmental Protection Agency (EPA) requested comment on a proposed framework to strengthen the assessment of antimicrobial-resistance risks associated with pesticide ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results